Angiotensin II-induced muscle atrophy via PPAR gamma suppression is mediated by miR-29b
Publication date
2021-03-05
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
cc_by_nc_nd
Abstract
The activation of the renin-angiotensin system (RAS) induced by increased angiotensin II (AngII) levels has been implicated in muscle atrophy, which is involved in the pathogenesis of congestive heart failure. Although peroxisome proliferator-activated receptor gamma (PPARγ) activation can suppress RAS, the exact role of PPARγ in AngII-induced muscle atrophy is unclear. Here we identified PPARγ as a negative regulator of miR-29b, a microRNA that is able to promote multiple types of muscle atrophy. Suppression of miR-29b could prevent AngII-induced muscle atrophy both in vitro and in vivo. IGF1, PI3K(p85α), and Yin Yang 1 (YY1) were identified as target genes of miR-29b, and overexpression of these targets could rescue AngII-induced muscle atrophy. Importantly, inhibition of PPARγ was sufficient to induce muscle atrophy, while PPARγ overexpression could attenuate that. These data indicate that the PPARγ/miR-29b axis mediates AngII-induced muscle atrophy, and increasing PPARγ or inhibiting miR-29b represents a promising approach to counteract AngII-induced muscle atrophy.
Keywords
angiotensin II, miR-29b, muscle atrophy, PPARγ, Drug Discovery, Molecular Medicine, Journal Article
Citation
Li, J, Yang, T, Sha, Z, Tang, H, Hua, X, Wang, L, Wang, Z, Gao, Z, Sluijter, J P G, Rowe, G C, Das, S, Yang, L & Xiao, J 2021, 'Angiotensin II-induced muscle atrophy via PPAR gamma suppression is mediated by miR-29b', Molecular therapy. Nucleic acids, vol. 23, pp. 743-756. https://doi.org/10.1016/j.omtn.2020.12.015